Literature DB >> 15864705

Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode.

Kay Mursch1, Svorad Trnovec, Heinrich Ratz, Detlef Hammer, Regine Horré, Albrecht Klinghammer, Sybren de Hoog, Julianne Behnke-Mursch.   

Abstract

RATIONALE: We report on a cerebral infection by Pseudallescheria boydii in a 21-month-old boy after a near-drowning episode. MRI revealed multiple (> 60) intracerebral abscesses.
METHODS: The surgical therapy included CSF drainage and microsurgical resection of one abscess for microbiological diagnosis. Antimycotic therapy included terbinafine and intraventricular caspofungin in addition to voriconazole.
RESULTS: Systemic side effects of chemotherapy were not observed. After placement of a ventriculoperitoneal shunt, the boy was transferred to a rehabilitation clinic and improved neurologically. After 20 months, MRI documented a continuing remission of the disease.
CONCLUSION: Our case proves that an aggressive treatment should be undertaken and can be successful in CNS pseudallescheriasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864705     DOI: 10.1007/s00381-005-1151-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

1.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Cerebral Pseudallescheria mycosis after near-drowning.

Authors:  R Rüchel; E Wilichowski
Journal:  Mycoses       Date:  1995 Nov-Dec       Impact factor: 4.377

3.  Near-drowning complicated by brain abscess due to Petriellidium boydii.

Authors:  J F Fisher; S Shadomy; J R Teabeaut; J Woodward; G E Michaels; M A Newman; E White; P Cook; A Seagraves; F Yaghmai; J P Rissing
Journal:  Arch Neurol       Date:  1982-08

Review 4.  Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.

Authors:  M A Nesky; E C McDougal; J E Peacock
Journal:  Clin Infect Dis       Date:  2000-09-27       Impact factor: 9.079

Review 5.  Pseudallescheria boydii infection of the central nervous system.

Authors:  P Kershaw; R Freeman; D Templeton; P C DeGirolami; U DeGirolami; D Tarsy; S Hoffmann; G Eliopoulos; A W Karchmer
Journal:  Arch Neurol       Date:  1990-04

6.  Activity of terbinafine against serious fungal pathogens.

Authors:  N S Ryder
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

Review 7.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 8.  The first echinocandin: caspofungin.

Authors:  O A Cornely; Karina Schmitz; Sabine Aisenbrey
Journal:  Mycoses       Date:  2002       Impact factor: 4.377

9.  Pseudallescheria boydii brain abscess. Complication of an intravenous catheter.

Authors:  R E Pérez; M Smith; J McClendon; J Kim; N Eugenio
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

Review 10.  Caspofungin acetate for treatment of invasive fungal infections.

Authors:  Staci A Pacetti; Steven P Gelone
Journal:  Ann Pharmacother       Date:  2003-01       Impact factor: 3.154

View more
  16 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

Review 2.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

Review 3.  [Fungal infections of the central nervous system in the immunocompetent host].

Authors:  K Tintelnot; G S de Hoog; G Haase
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 4.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.

Authors:  Peter Troke; Koldo Aguirrebengoa; Carmen Arteaga; David Ellis; Christopher H Heath; Irja Lutsar; Montserrat Rovira; Quoc Nguyen; Monica Slavin; Sharon C A Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

Review 7.  Recent Advances in the Treatment of Scedosporiosis and Fusariosis.

Authors:  Matthew W McCarthy; Aspasia Katragkou; Elias Iosifidis; Emmanuel Roilides; Thomas J Walsh
Journal:  J Fungi (Basel)       Date:  2018-06-18

8.  Combination Antifungal Therapy in the Treatment of Scedosporium apiospermum Central Nervous System Infections.

Authors:  Andrés F Henao-Martínez; José R Castillo-Mancilla; Michelle A Barron; Aran Cunningham Nichol
Journal:  Case Rep Infect Dis       Date:  2013-04-29

9.  Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection.

Authors:  John R Williams; Mark W Tenforde; Jeannie D Chan; Andrew Ko; Susan M Graham
Journal:  Med Mycol Case Rep       Date:  2016-07-09

10.  The Neurotropic Black Yeast Exophiala dermatitidis Induces Neurocytotoxicity in Neuroblastoma Cells and Progressive Cell Death.

Authors:  Teja Lavrin; Tilen Konte; Rok Kostanjšek; Simona Sitar; Kristina Sepčič; Sonja Prpar Mihevc; Ema Žagar; Vera Župunski; Metka Lenassi; Boris Rogelj; Nina Gunde Cimerman
Journal:  Cells       Date:  2020-04-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.